The comparison between FDG-PET and RECIST in detection and duration of response to RAD001 in patients with metastatic renal cell cancer (mRCC).

R. Mody,G. K. Doshi,R. J. Amato

The comparison between FDG-PET and RECIST in detection and duration of response to RAD001 in patients with metastatic renal cell cancer (mRCC).

2010

R. Mody
G. K. Doshi
R. J. Amato

e15077 Background: A phase II study assessing the activity of RAD001 (Afinitor) in patients with metastatic clear cell renal cell carcinoma has been published in Cancer, 2009 115(11). The purpose i...

Keywords:

Oncology
Metastatic renal cell cancer
Internal medicine
Pathology
Medicine
Cancer
in patient
Phases of clinical research
Clear cell renal cell carcinoma

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations